Blue Notes
| dc.contributor.author | Kahi, Charles J. | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2023-07-10T17:01:05Z | |
| dc.date.available | 2023-07-10T17:01:05Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Comment on: doi: 10.1016/j.cgh.2022.02.030; doi: 10.1016/j.cgh.2021.12.032; doi: 10.1016/j.cgh.2021.06.020; doi: 10.1016/j.cgh.2021.11.031 | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Kahi CJ. Blue Notes. Clin Gastroenterol Hepatol. 2022;20(7):1425-1426. doi:10.1016/j.cgh.2022.04.007 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/34293 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.cgh.2022.04.007 | en_US |
| dc.relation.journal | Clinical Gastroenterology and Hepatology | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | COVID-19 vaccination | en_US |
| dc.subject | Vaccine effectiveness | en_US |
| dc.subject | Immunocompromised individuals | en_US |
| dc.subject | Inflammatory bowel disease | en_US |
| dc.subject | Seroconversion | en_US |
| dc.title | Blue Notes | en_US |
| dc.type | Article | en_US |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191885/ | en_US |